Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2008 1
2010 3
2011 4
2012 4
2013 2
2015 1
2017 1
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.
Friebe A, Siegling A, Weber O. Friebe A, et al. Among authors: weber o. J Microbiol Immunol Infect. 2018 Oct;51(5):587-592. doi: 10.1016/j.jmii.2017.03.002. Epub 2017 Jun 27. J Microbiol Immunol Infect. 2018. PMID: 28711432 Free article.
Cholesteryl ester transfer protein and its inhibition.
Weber O, Bischoff H, Schmeck C, Böttcher MF. Weber O, et al. Cell Mol Life Sci. 2010 Sep;67(18):3139-49. doi: 10.1007/s00018-010-0418-3. Epub 2010 Jun 18. Cell Mol Life Sci. 2010. PMID: 20556633 Review.
AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.
Paulsen D, Weber O, Ruebsamen-Schaeff H, Tennant BC, Menne S. Paulsen D, et al. Among authors: weber o. PLoS One. 2015 Dec 14;10(12):e0144383. doi: 10.1371/journal.pone.0144383. eCollection 2015. PLoS One. 2015. PMID: 26656974 Free PMC article.
Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis.
Nowatzky J, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Limmer A, Knolle P, Weber O. Nowatzky J, et al. Among authors: weber o. Hepatol Res. 2013 May;43(5):535-46. doi: 10.1111/j.1872-034X.2012.01086.x. Epub 2012 Sep 13. Hepatol Res. 2013. PMID: 22971208
Characterization of immunostimulatory components of orf virus (parapoxvirus ovis).
Friebe A, Friederichs S, Scholz K, Janssen U, Scholz C, Schlapp T, Mercer A, Siegling A, Volk HD, Weber O. Friebe A, et al. Among authors: weber o. J Gen Virol. 2011 Jul;92(Pt 7):1571-1584. doi: 10.1099/vir.0.028894-0. Epub 2011 Feb 23. J Gen Virol. 2011. PMID: 21346027
Inactivated ORF virus shows antifibrotic activity and inhibits human hepatitis B virus (HBV) and hepatitis C virus (HCV) replication in preclinical models.
Paulsen D, Urban A, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Mercer AA, Limmer A, Schumak B, Knolle P, Ruebsamen-Schaeff H, Weber O. Paulsen D, et al. Among authors: weber o. PLoS One. 2013 Sep 16;8(9):e74605. doi: 10.1371/journal.pone.0074605. eCollection 2013. PLoS One. 2013. PMID: 24066148 Free PMC article.
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
Schwandt T, Schumak B, Gielen GH, Jüngerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A. Schwandt T, et al. Among authors: weber o. EMBO J. 2012 Jan 4;31(1):201-13. doi: 10.1038/emboj.2011.380. Epub 2011 Oct 28. EMBO J. 2012. PMID: 22036947 Free PMC article.
Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein.
Boettcher MF, Heinig R, Schmeck C, Kohlsdorfer C, Ludwig M, Schaefer A, Gelfert-Peukert S, Wensing G, Weber O. Boettcher MF, et al. Among authors: weber o. Br J Clin Pharmacol. 2012 Feb;73(2):210-8. doi: 10.1111/j.1365-2125.2011.04083.x. Br J Clin Pharmacol. 2012. PMID: 21838789 Free PMC article. Clinical Trial.
Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.
Weber O, Willmann S, Bischoff H, Li V, Vakalopoulos A, Lustig K, Hafner FT, Heinig R, Schmeck C, Buehner K. Weber O, et al. Br J Clin Pharmacol. 2012 Feb;73(2):219-31. doi: 10.1111/j.1365-2125.2011.04064.x. Br J Clin Pharmacol. 2012. PMID: 21762205 Free PMC article.
19 results
Jump to page
Feedback